Shreeram Aradhye
to talk about Medical Affairs
and lorem ipsom et lorteum
Shreeram Aradhye
to talk about Medical Affairs
and lorem ipsom et lorteum
THE OCTOBER ISSUE
OF GOLD IS HERE!
Check out the new issue of GOLD! From the lessons pharma can learn from the tech giants to the sector’s work to reduce, refine and replace animal testing, the latest issue of GOLD considers the most pressing issues, trends and triumphs facing the industry today.
October 2022
Featuring a host of insight from industry thought leaders, this issue covers the rise of alternative drug development models and treatments, the industry’s response to landmark legislation changes in the US, the rise and fall of biotech investment and much more.
Topics include:
-
Non-drug treatments
-
AI in drug discovery
-
Pharma’s response to Roe v. Wade
-
A revealing conversation with Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology
August 2022
Speaking with industry experts, this issue features an investigation into the future for MSLs, thoughts on the potential that social media holds for pharma and patients alike and a voyage to India to explore the country’s bustling pharma landscape.
Additional topics include:
-
Building trust in genomics
-
Disparities in women’s health
-
Digital twins
-
A thought-provoking conversation with Dr Juby Jacob-Nara, Vice President and Global Medical Head for Respiratory, Allergy, and Gastro-Intestinal Diseases, Sanofi
June 2022
Featuring insight from a broad spectrum of experts, this issue explores key trends within the pharma industry including the ever-present issue of non-adherence, patient centricity from the patient perspective, the allure of public-private partnerships and much more.
Additional topics include:
-
Ensuring first-time launch success
-
Reverse mentoring
-
Brazil’s strengthening pharma landscape
-
A discussion with Claus Zieler, President, Established Markets, Astellas
The GOLD archive
Click the navigation arrows to scroll through each of GOLD's past issues. Click on a cover to read the issue and download.
YOU MIGHT ALSO LIKE..
R&D
Artificially intelligent drug discovery
AI is being implemented into the drug development process to free up time, money and manpower, but how can humans and computers work together?
Innovation
An opportunity to crack the opioid crisis
Despite moves in a positive direction, opioid abuse shows little sign of abating. What role can pharma play in addressing the crisis?
News
Pharma in
Kenya
Kenya is home to a budding pharma sector, but the country is still blighted by a series of access to medicine challenges. What are these, and how can pharma help?